Market revenue in 2023 | USD 58.1 million |
Market revenue in 2030 | USD 94.2 million |
Growth rate | 7.1% (CAGR from 2023 to 2030) |
Largest segment | Isotonic crystalloids |
Fastest growing segment | Dextrose solutions |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Isotonic crystalloids, Synthetic colloids, Blood products, Dextrose solutions, Parenteral nutrition |
Key market players worldwide | Merck & Co Inc, Baxter International Inc, Dechra Veterinary Products, Sypharma, B. Braun, Woods Consulting, Fresenius Kabi, Fresenius SE & Co KGaA |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary intravenous (iv) solutions market will help companies and investors design strategic landscapes.
Isotonic crystalloids was the largest segment with a revenue share of 42.51% in 2023. Horizon Databook has segmented the Middle East & Africa veterinary intravenous (iv) solutions market based on isotonic crystalloids, synthetic colloids, blood products, dextrose solutions, parenteral nutrition covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa veterinary intravenous (iv) solutions market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa veterinary intravenous (iv) solutions market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account